Eisha Shoaib

Eisha Shoaib

Auto-generated profile, based on publicly available information

Eisha Shoaib

School of Medicine Karachi Medical and Dental College Karachi Pakistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2025 in Medicine Advances
Verified
Journal Article
Open access
SKSaim Mahmood Khan
Saim Mahmood Khan
MAMarium Amjad
Marium Amjad
RSRida Shakil
Rida Shakil
ESEisha Shoaib
Eisha Shoaib
DKDong Hwi Kim
Dong Hwi Kim
JHJawairya Muhammad Hussain
Jawairya Muhammad Hussain
Diacerein, an anthraquinone derivative, has gained interest in recent years as a potential therapeutic agent in the management of knee osteoarthritis (KOA), particularly the inflammatory subtype effusion synovitis. This commentary evaluates the effect of diacerein on KOA symptoms and functional outcomes of recent parts of a multicenter randomized controlled trial. The clinical trial of diacerein as a monotherapy for effusion synovitis concluded that not only was there no overall significant change in the knee joint's moisture content after a 24‐week therapy but also there was no evidence of symptomatic or functional improvement. Furthermore, problems like diarrhea and colored urine raised questions about its safety and user‐friendly profile; therefore, these findings were contentious. These outcomes highlight the need for greater investigation of diacerein, including in combination therapies where its benefits are amplified and adverse effects diminished. Further research should help to define diacerein's role in KOA treatment and increase the understanding of its actions regarding effusion synovitis, focusing on side effects.